AKT1 and liver cancer: Indeed, our findings now demonstrate that Trip13 regulates Akt activation, mainly mediated through the IR (a MIM containing protein), with Trip13 being a key player in the p31comet‐/Mad2‐dependent regulation of insulin signaling in liver cancer cells.